You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

Dorzolamide hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for dorzolamide hydrochloride and what is the scope of patent protection?

Dorzolamide hydrochloride is the generic ingredient in five branded drugs marketed by Alembic, Am Regent, Bausch And Lomb, Fdc Ltd, Gland Pharma Ltd, Hikma, Indoco, Micro Labs, Rubicon, Sandoz, Teva Pharms, Zambon Spa, Msd Sub Merck, Thea Pharma, Chartwell Molecular, Epic Pharma Llc, Eugia Pharma, Ingenus Pharms Llc, and Somerset, and is included in thirty-five NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for dorzolamide hydrochloride. Twelve suppliers are listed for this compound.

Summary for dorzolamide hydrochloride
US Patents:0
Tradenames:5
Applicants:19
NDAs:35
Drug Master File Entries: 14
Finished Product Suppliers / Packagers: 12
Raw Ingredient (Bulk) Api Vendors: 92
Clinical Trials: 56
Patent Applications: 587
What excipients (inactive ingredients) are in dorzolamide hydrochloride?dorzolamide hydrochloride excipients list
DailyMed Link:dorzolamide hydrochloride at DailyMed
Recent Clinical Trials for dorzolamide hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Laboratorios PoenPhase 4
Shahid Beheshti University of Medical SciencesPhase 2/Phase 3
Salus UniversityPhase 4

See all dorzolamide hydrochloride clinical trials

Pharmacology for dorzolamide hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for dorzolamide hydrochloride
Paragraph IV (Patent) Challenges for DORZOLAMIDE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
TRUSOPT Ophthalmic Solution dorzolamide hydrochloride 2% 020408 1 2005-10-11

US Patents and Regulatory Information for dorzolamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 215520-001 Sep 19, 2022 AT1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zambon Spa DORZOLAMIDE HYDROCHLORIDE dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 091034-001 Dec 4, 2013 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Msd Sub Merck TRUSOPT dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 020408-001 Dec 9, 1994 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Indoco DORZOLAMIDE HYDROCHLORIDE dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 202053-001 Sep 11, 2014 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 213099-001 May 4, 2021 AT1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic DORZOLAMIDE HYDROCHLORIDE dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 212639-001 Aug 9, 2019 AT RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Eugia Pharma DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE dorzolamide hydrochloride; timolol maleate SOLUTION/DROPS;OPHTHALMIC 207629-001 May 14, 2021 AT1 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for dorzolamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Msd Sub Merck TRUSOPT dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 020408-001 Dec 9, 1994 ⤷  Sign Up ⤷  Sign Up
Msd Sub Merck TRUSOPT dorzolamide hydrochloride SOLUTION/DROPS;OPHTHALMIC 020408-001 Dec 9, 1994 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.